Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20062830HPVENSG00000182674.6protein_codingKCNB2NoNo9312Q92953
TVIS20019361HPVENSG00000182674.6protein_codingKCNB2NoNo9312Q92953
TVIS20035839HPVENSG00000182674.6protein_codingKCNB2NoNo9312Q92953
TVIS20066550HPVENSG00000182674.6protein_codingKCNB2NoNo9312Q92953
TVIS20063064HPVENSG00000182674.6protein_codingKCNB2NoNo9312Q92953
TVIS20032994HPVENSG00000182674.6protein_codingKCNB2NoNo9312Q92953
TVIS20033475HPVENSG00000182674.6protein_codingKCNB2NoNo9312Q92953
TVIS20039626HPVENSG00000182674.6protein_codingKCNB2NoNo9312Q92953
TVIS20041307HPVENSG00000182674.6protein_codingKCNB2NoNo9312Q92953
TVIS20035400HPVENSG00000182674.6protein_codingKCNB2NoNo9312Q92953
TCGA Plot Options
Drug Information
GeneKCNB2
DrugBank IDDB06637
Drug NameDalfampridine
Target IDBE0004722
UniProt IDQ92953
Regulation Typeantagonist
PubMed IDs16472864
CitationsJudge SI, Bever CT Jr: Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther. 2006 Jul;111(1):224-59. Epub 2006 Feb 9.
GroupsApproved
Direct ClassificationAminopyridines and derivatives
SMILESNC1=CC=NC=C1
Pathways
PharmGKBPA166123389
ChEMBLCHEMBL284348